Contract 75A50325C00004
Fresenius Kabi, Llc · Department Of Health And Human Services · September 11, 2025
Fresenius Kabi, Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 11, 2025 for $36.26 million of work in pharmaceutical preparation manufacturing. Performance is in Lake Zurich, IL. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $149.41 million.
Contract details
- PIID
- 75A50325C00004
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Lake Zurich, IL
- First action
- September 11, 2025
Description
BULK PHARMA - GROUP B (ASSET MGMT) ACYCLOVIR SODIUM SOLUTION, DOXYCYCLINE INJ., MEROPENEM, SODIUM CHLORIDE, STERILE WATER
Modification timeline
-
September 11, 2025Mod P00001 · Exercise An Option$86.26M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50325C00004?
Contract 75A50325C00004 is a federal contract awarded to Fresenius Kabi, Llc by Department Of Health And Human Services on September 11, 2025 for $36.26 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50325C00004?
Fresenius Kabi, Llc won contract 75A50325C00004 from Department Of Health And Human Services.
How much is contract 75A50325C00004 worth?
Contract 75A50325C00004 has obligated $36.26 million to date, with a total potential value of $149.41 million if all options are exercised.